Target residues

Golovanevsky, V. and Kanner, B. I. (1999) The reactivity of the gamma-aminobutyric acid transporter GAT-1 toward sulfhydryl reagents is conformationally sensitive. Identification of a major target residue. J. Biol. Chem. 274,23020-23026. 

Figure 4.19 Tyrosine kinase (a) portion of a primary sequence containing a tyrosine target residue (b) structure...

The use of sophisticated instrumental systems such as high-resolution GC-MS does not guarantee satisfactory quantitation of the hundreds of chemicals sometimes present in SPMDs without some fractionation of sample residues. Thus, the complexity of target residues, as well as interferences from the matrix sampled can be determinants in the cleanup and separation procedures needed for satisfactory analyses. The following discussion presents the salient features of the typical processing and analytical procedures applied to SPMD samples. 

Not all laboratories use SEC for the cleanup of SPMD dialysates. Eor example, Booij et al. (2003) used a 0.6 cm i.d. column containing 2 g of silica gel 60 (deactivated with 6% water [wt/wt]) obtained from Merck, Whitehouse Station, NJ, USA to purify dialysates from 1 mL triolein SPMDs. The concentrated dialysates were applied to the silica gel columns, and PAHs and PCBs were quantitatively eluted with 40 mL of high purity pentane. Less than 0.01 mg of non-target residues coeluted with analytes in the pentane. 

There are two basic considerations when attempting SDM. One is to determine the amino acids that should be mutated and the other is to decide what to replace them with. The first question is, of course, dependant upon information gathered from previous experimentation in order to target residues that are appropriate. Such information may be derived from biochemical techniques. For instance, in our binding site studies, we have specifically mutated amino acids that had previously shown to be covalently labeled by photoactive ligands. Additionally, we have used comparisons between the sequences of different receptor subunits that correlate with receptor function to identify domains of interest. Chimeragenesis, the technique described in the first half of this chapter, can provide important information in this regard. Obviously, those proteins for which a detailed structural model is available will lend themselves to more rational substitutions. 

Since it is difficult, in practical terms, for a monitoring plan to measure analytically a series of residues with widely differing chemical structures, control exigencies require that MRL values be expressed in terms of a single chemical entity, know as the marker residue. It is important that die contents of this marker residue evolve in the different tissues of treated animals in proportion to all targeted residues, if it is to reflect them. For obvious practical reasons, this marker residue must also satisfy two requisites it must permit a practical dosage and must be commercially or otherwise available for tire purposes of official controls. 

Figure 7.5 Example of a chimeric oligonucleic acid and its modification. Chimeric RNA-DNA hybrids are used for correction of point mutations in target genes. One strand of this oligonucleic acid is composed of O-methyl-RNA (outline) with an interruption of 5 bases of deoxyribonucleic acid. X and Y are target residues for correction. In the complementary strand, there is a DNA nick, and T residues loop both ends. 3 -exonuclease and FEN-1 may act on the nick, PARP-1 possibly binds to and is activated by the nick, resulting in activation of damage response pathways. In the modified version, the 3 end is replaced by ribonucleic acids. The 5 end is extended, and the flipped back RNA tail is added. Thus, the nick is expected to be resistant to 3 -exonuclease and FEN-1. In addition, PARP-1 may not be activated by such a nick.

In vitro, with CaATP as a substrate, E. coli dnaK autophosphorylates exclusively at Thr-199 (McCarty and Walker, 1991). It does not auto-phosphorylate when MgATP is used as a substrate. In vivo, dnaK is found to be phosphorylated on serine as well as on threonine residues (Rieul et al., 1987). Under normal growth conditions, phosphorylation is primarily on serine when E. coli is infected with bacteriophage M13, the phosphorylation shifts predominantly to threonine, with minor phosphorylation of serine. The specific target residues of in vivo phosphorylation of dnaK have not yet been determined. The disparity between the in vitro results (autophosphorylation exclusively at Thr-199 an absolute requirement for CaATP) and the in vivo results (phosphorylation on both serine and threonine residues, under conditions in which MgATP would be presumed to be the available intracellular substrate nucleotide) raises the questions of (1) whether the specific autophosphorylation of Thr-199 observed in vitro also occurs in vivo, or whether it may be an artifactual side reaction when the larger Ca ion is substituted for Mg" at the active site of the protein, and (2) whether there is a serine/threonine protein kinase that specifically phosphorylates dnaK in vivo. 

The identification of Gdk4-specific amino acid residues allowed us to focus on target residues that interact with substituents on lead compounds. Library design based on the locations of these residues and the binding modes of lead compounds enabled us to develop potent and selective compounds efficiently. Among them, compound 11 showed excellent selectivity not only over Cdkl/2 (780-fold/... 

For most oils, the targeted residual FFA content is 0.03-0.05%. Figure 3 shows the effect of pressure and temperature on FFA stripping from Cig-rich oils in a cross-flow-type deodorizer. With packed columns, stripping steam consumption is about 20-30% lower because of the countercurrent stripping effect. 

For residues (such as cleaning agents) that do not have a defined dose, some measure of toxicity, such as an acceptable daily intake (ADI), is used for residue limit purposes. If the subsequently manufactured product is an in vitro diagnostic (IVD), and has no defined dose, then some evaluation of the effects of target residues on the performance or stability of the IVD product should be performed. These non-dose factors are used only for the Li limit there are no changes for calculation of L2 and L3 limits. 

The sampling method chosen must be challenged in combination with the analytical procedure to determine the recovery of the sampling method. This is typically a laboratory study involving spiking a model surface with the target residue and performing the... 

---